EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 11-Jul-2025 06:10 ET (11-Jul-2025 10:10 GMT/UTC)

Damon Runyon Cancer Research Foundation awards $4.4 million to top young scientists

Damon Runyon Cancer Research Foundation
Grant and Award Announcement

The Damon Runyon Cancer Research Foundation has named 13 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators. The prestigious, four-year Fellowship encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding ($300,000 total) to investigate cancer causes, mechanisms, therapies, and prevention.

New antibodies show potential to defeat all SARS-CoV-2 variants

Stanford University
Peer-Reviewed Publication

A Stanford-led team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the approach shows promise in developing treatments to keep pace with evolving viruses.

Research identifies key antibodies for development of broadly protective norovirus vaccine

University of Texas at Austin
Peer-Reviewed Publication

Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study, published in Science Translational Medicine, identifies powerful antibodies capable of neutralizing a wide range of norovirus strains. The finding could lead to the design of broadly effective norovirus vaccine, as well as the development of new therapeutic antibodies for the treatment of norovirus-associated gastroenteritis.

Journal: Science Translational Medicine

New drug shows promise in treating liver disease caused by metabolic dysfunction, cancer

University of Texas Health Science Center at San Antonio
Peer-Reviewed Publication

The groundbreaking study demonstrates drug candidate can safely and effectively target and eliminate senescent cells, also known as “zombie cells,” from the liver.

Journal: Nature Aging

Cancer screening 3 years after the onset of the COVID-19 pandemic

JAMA Network
Peer-Reviewed Publication

About The Study: In 2023, reported breast and colorectal cancer screening rebounded from COVID-19 pandemic–related declines and surpassed pre-pandemic estimates. These findings are encouraging given larger-than-expected declines in early-stage breast and colorectal cancer diagnoses in 2020 and increases in distant-stage breast cancer diagnoses through 2021. Cervical cancer screening rates remained below pre-pandemic levels, a troubling trend as early-stage diagnoses continued to decrease in 2021. The persistent decline may in part reflect longer-term declines in patient knowledge and clinician recommendation of cervical cancer screening.

Journal: JAMA

Scientists discover how aspirin could prevent some cancers from spreading

UK Research and Innovation
Peer-Reviewed Publication

Scientists have uncovered the mechanism behind how aspirin could reduce the metastasis of some cancers by stimulating the immune system, in a new study primarily funded by the Medical Research Council. In the study, published in Nature, the scientists say that discovering the mechanism will support ongoing clinical trials, and could lead to the targeted use of aspirin to prevent the spread of susceptible types of cancer, and to the development of more effective drugs to prevent cancer metastasis.

Journal: Nature

A new way to predict cancer's spread? Scientists look at 'stickiness' of tumor cells

University of California - San Diego
Peer-Reviewed Publication

By assessing how “sticky” tumor cells are, UC San Diego researchers have found a potential way to predict whether a patient’s early-stage breast cancer is likely to spread. The discovery could help doctors identify high-risk patients and tailor their treatments accordingly.

Journal: Cell Reports
Funder: NIH/National Institutes of Health, U.S. National Science Foundation, NIH/National Cancer Institute

Scientists design experimental protein booster for rare genetic diseases

Johns Hopkins Medicine
Peer-Reviewed Publication

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins. To boost those proteins, they’ve created experimental versions of a genetic “tail” that attaches to so-called mRNA molecules that churn out the proteins.

The development of a risk prediction model to predict patients’ likelihood of completing human papillomavirus vaccination

Xia & He Publishing Inc.
Peer-Reviewed Publication

Human papillomavirus (HPV) infection is the primary cause of cervical, anogenital, and oropharyngeal cancers in the United States. These cancers are preventable through HPV vaccination. Research is critically needed to identify effective strategies for promoting HPV vaccination among high-risk groups. This study develops a risk prediction model to identify patients who are unlikely to complete HPV vaccination, with the goal of using the model to direct resources and increase vaccination rates.

Journal: Cancer Screening and Prevention

Toxic environmental pollutants linked to faster aging and health risks in US adults

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — March 5, 2025 — A new research paper was published in Aging (Aging-US) on February 11, 2025, Volume 17, Issue 2, titled “Exposome-wide association study of environmental chemical exposures and epigenetic aging in the national health and nutrition examination survey.”

Journal: Aging-US